Editas Medicine, Inc. (29)

Browse by Contract Category

Contracts

Omnibus Amendment, dated as of January 11, 2021, by and between the Registrant and Broad (Filed With SEC on February 26, 2021)
Employment Offer Letter, dated February 14, 2021, between the Registrant and James C. Mullen (Filed With SEC on February 26, 2021)
Underwriting Agreement, dated January 20, 2021, by and among the Company, J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC (Filed With SEC on January 21, 2021)
Termination Agreement, dated August 5, 2020, by and between the Company and Allergan Sales, LLC (Filed With SEC on November 6, 2020)
License and Agreement, dated November 11, 2019, between the Registrant and Juno (Filed With SEC on February 26, 2020)
Employment Offer Letter, dated September 25, 2020, between the Registrant and Lisa A. Michaels, M.D (Filed With SEC on February 26, 2021)
Letter Agreement, dated February 15, 2021, by and between the Registrant and Cynthia Collins (Filed With SEC on February 26, 2021)
First Amendment to Sponsored Research Agreement, dated January 11, 2021, between the Registrant and Broad (Filed With SEC on February 26, 2021)
Summary of Director Compensation Program (Filed With SEC on February 26, 2021)
Advisory Services Agreement, Dated May 1, 2020, by and between the Company and Judith Abrams (Filed With SEC on August 7, 2020)
Separation Agreement, dated as of April 30, 2020, by and between the Company and Judith Abrams (Filed With SEC on August 7, 2020)
Underwriting Agreement, dated June 23, 2020, by and between the Company and the Underwriter (Filed With SEC on June 25, 2020)
Common Stock Sales Agreement, dated as of May 15, 2020, by and between the Company and Cowen (Filed With SEC on May 15, 2020)
Second Amended and Restated License and Collaboration Agreement, dated November 11, 2019, between the Registrant and Juno Therapeutics, Inc. (Juno) (Filed With SEC on February 26, 2020)
Letter Agreement, dated as of November 18, 2019, by and among, the Registrant, Broad and Harvard (Filed With SEC on February 26, 2020)
Letter Agreement, dated as of December 16, 2019, by and among, the Registrant, Broad and Harvard (Filed With SEC on February 26, 2020)
Amended Severance Benefits Plan (Filed With SEC on February 26, 2020)
Form of Inducement Restricted Stock Unit Award Agreement for the Registrants executive officers (Filed With SEC on February 26, 2020)
Form of Inducement Stock Option Agreement for the Registrants executive officers (Filed With SEC on February 26, 2020)
Employment Offer Letter, dated December 27, 2019, between the Registrant and Michelle Robertson (Filed With SEC on February 26, 2020)
Employment Offer Letter, dated October 11, 2019, between the Registrant and Judith R. Abrams, M.D (Filed With SEC on February 26, 2020)
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 26, 2020)
Letter Agreement, dated September 26, 2019, by and between the Registrant and Vic Myer, Ph.D (Filed With SEC on November 12, 2019)
Offer Letter, dated August 6, 2019, by and between the Registrant and Cynthia Collins (Filed With SEC on November 12, 2019)
Co-Development and Commercialization Agreement, dated February 22, 2019, by and between the Registrant and Allergan Sales, LLC (Filed With SEC on May 8, 2019)
Consulting Agreement, dated January 20, 2019, by and between the Registrant and Cynthia Collins (Filed With SEC on May 8, 2019)
Letter Agreement, dated January 19, 2019, by and between the Registrant and Katrine Bosley (Filed With SEC on May 8, 2019)
Separation Agreement, by and between the Registrant and Gerald Cox, M.D., Ph.D (Filed With SEC on March 1, 2019)
Form of Restricted Stock Unit Award Agreement under 2015 Stock Incentive Plan (Filed With SEC on January 22, 2019)